SUPERNUS PHARMACEUTICALS, INC.

By person

11 insiders · 33 transactions

107×

Jack A. Khattar holds 107 times base salary in stock. $111.89M of shares against $1.04M in salary for 2025.

Salary from the company's own proxy. The shares are what Jack A. Khattar last reported holding, valued at $50.48, the price Common Stock was last bought or sold at on the open market here, on 18 Mar 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Khattar Jack A.

President, CEO

—

$9.89M (11) scheduled

−$9.89M

2,216,451

3.81%

$111.89M

+13.7%

Bhatt Padmanabh P.

Sr. VP of IP, CSO

—

$5.42M (7) scheduled

−$5.42M

18,637

0.0321%

$940.80K

+67.3%

NEWHALL CHARLES W III

Director

—

$1.27M (2) scheduled

−$1.27M

124,119

0.2135%

$6.27M

+2.6%

Mottola Frank

SVP, Chief Tech. Ops. Officer

—

$1.10M (3) scheduled

−$1.10M

19,544

0.0336%

$986.58K

+110.7%

GEMAYEL GEORGES

Director

—

$1.00M (2)

−$1.00M

27,277

0.0469%

$1.38M

+104.9%

Horich William Todd

SVP, Commercial Operations

—

$483.80K (2)

−$483.80K

0.0000%

$0.00

−100.0%

Hudson Frederick M.

Director

—

$271.73K (1)

−$271.73K

60,413

0.1039%

$3.05M

+62.8%

Sensenig Bethany

Director

—

$228.26K (2) scheduled

−$228.26K

0.0000%

$0.00

—

Barlow Carrolee

Director

—

27,045

0.0465%

$1.37M

+57.2%

Rubin Jonathan

SVP, Chief Medical Officer

—

13,979

0.0240%

$705.66K

+123.8%

DEC TIMOTHY C

Senior Vice-President & CFO

—

9,129

0.0157%

$460.83K

+0.6%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Bhatt Padmanabh P.

18 Mar 2026

Sr. VP of IP, CSO

Sold after exercise

412

$50.48

$20.80K

Bhatt Padmanabh P.

18 Mar 2026

Sr. VP of IP, CSO

Sold after exercise

6,838

$49.55

$338.82K

Bhatt Padmanabh P.

17 Mar 2026

Sr. VP of IP, CSO

Sold after exercise

22,290

$50.73

$1.13M

Bhatt Padmanabh P.

17 Mar 2026

Sr. VP of IP, CSO

Sold after exercise

27,710

$49.95

$1.38M

Bhatt Padmanabh P.

16 Mar 2026

Sr. VP of IP, CSO

Sold after exercise

15,886

$50.49

$802.08K

Bhatt Padmanabh P.

16 Mar 2026

Sr. VP of IP, CSO

Sold after exercise

34,114

$50.18

$1.71M

GEMAYEL GEORGES

6 Mar 2026

Director

Sold after exercise

8,787

$53.00

$465.71K

Sensenig Bethany

19 Feb 2026

Director

Sold after exercise

3,258

$51.27

$167.04K

Sensenig Bethany

19 Feb 2026

Director

Sold after exercise

1,217

$50.31

$61.23K

Mottola Frank

19 Dec 2025

SVP, Chief Tech. Ops. Officer

Sold after exercise

15,000

$50.47

$757.05K

Mottola Frank

19 Dec 2025

SVP, Chief Tech. Ops. Officer

Sold after exercise

5,000

$50.22

$251.10K

Bhatt Padmanabh P.

18 Dec 2025

Sr. VP of IP, CSO

Sold after exercise

710

$44.44

$31.55K

Khattar Jack A.

9 Oct 2025

President, CEO

Sold after exercise

1,529

$51.46

$78.68K

Khattar Jack A.

9 Oct 2025

President, CEO

Sold after exercise

58,371

$50.55

$2.95M

Khattar Jack A.

2 Oct 2025

President, CEO

Sold after exercise

1,904

$48.06

$91.51K

Khattar Jack A.

1 Oct 2025

President, CEO

Sold after exercise

40,173

$48.07

$1.93M

Khattar Jack A.

30 Sep 2025

President, CEO

Sold after exercise

8,588

$48.25

$414.37K

Khattar Jack A.

29 Sep 2025

President, CEO

Sold after exercise

10,235

$48.02

$491.48K

Khattar Jack A.

23 Sep 2025

President, CEO

Sold after exercise

29,513

$47.23

$1.39M

Khattar Jack A.

22 Sep 2025

President, CEO

Sold after exercise

16,587

$47.02

$779.92K

Show all 33 transactions →

SUPERNUS PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out